Today, biomaterial-based solutions play an important role in clinical applications.
They can be implemented e.g. astissue repair scaffolds or replace elements of damaged body parts. As these biomaterials directly interact with the human body, unforseen adverse reactions can occur.
PANBioRA will develop a tool to better assess a patient-specific immune reaction to biomaterials and thus allow improved clinical outcomes.
Components of the PANBioRa biomaterial risk assessment system








PROJECT NEWS
PANBioRA will be present at the virtual World Biomaterials Congress 2020!
Dr. Nihal Engin Vrana will hold a Keynote Lecture on personalised, multifunctional coatings for medical devices against infections and adverse immune reactions
Dr. Nihal Engin Vrana presents the PANBioRA project in a NanoAlb web seminar.
image credits: www.elveflow.com

Upcoming Events
Open Science for Enhanced Global Environmental Protection
Latest Tweets
